chrisvoncsefalvay/vaers-outcomes huggingface dataset:
There were no immediate reactions during the 15 minute wait period. 45 minutes after my injection, while at a different Walgreens where my friend received a Moderna jab, I was hit with a rush of side effects. The first was a deep gripping pain in the diaphragm area, like a punch to the stomach with some dizziness.   While seated, my left leg experienced increasing pain from foot to hip.  In short order, my left foot grew completely numb and this extended up my calf to my knee. My foot became paralyzed. Rather than go through a lengthy emergency room procedure, we drove back and luckily, the numbness did not spread. The intense leg pain remained steady. Breathing labored. At my friend's house, the left foot & calf numbing and paralysis finally subsided 4.5 hours after injection. At home, some numbness returned but subsided. Sat. through Wednesday, 2-28 to 3-3-21:  Weakness in left leg. Cramping of calf muscle. The chest cavity pain began to intensify. Chills arrive plus daily headaches. These start to resemble reported "normal" reactions minus the special situation of the left leg. Pain while deeply inhaling, exhaling or bending increasing. Fatigue - partly from poor sleep.  Thur. 3-4-21  Day 7:  Still with strong muscle or lung pain, especially upper back. Painful to pull back shoulders. Periodic sharp pain in upper left inner arm, not at injection site. Still pain with deep exhale or inhale. Tried a short walk: After 200 feet, left calf tightening up and pain increasing in both hips. A short rest would clear it but would return with exercise. Lower back pain as well but some of that is pre-existing.  Basic circle of pain around rib cage. Skin (or deeper tissue?) on my upper back still very sensitive, resembling sunburn. Produces chills when touched. Sleep still nearly impossible. No sleep aids being used.  Fatigue, some headache and chills remain. During this period, I have resorted to pain relievers only twice in order to learn the nature of the symptoms.  Fri. 3-5-21  Day 8 During this reaction period: NO fever, nausea, diarrhea, loss of taste / smell, sore throat, congestion or runny nose. Headache, chills, joint & ribcage pain remain. Skin hypersensitive on my upper back. Symptoms today same as on 3-4-21. Moderate morning headache. On a 1.5 mile walk, slight improvement with the left calf muscle cramping. Occasional "clearing" cough, small amount of clear phlegm produced.
Several hours after getting the vaccine, my back spasmed out and the pain was continuous and I still have the upper back pain today. That same evening I developed the chills, stomach pain. The next day I began experiencing a fever, headache, nausea, light headedness, dizziness, chills, back pain, lock jaw, some numbness on left side of face, zoning out or spacing out. My period also came two weeks early. I had some throat irritation as well as the feeling of being weak and some neck stiffness. All these symptoms seem to have gone away by Sunday evening, if not Monday morning. Except for the back pain, the nausea, and the throat irritation and some head pain and some numbness in face seem to have persisted.
chills, severe muscle aches, severe shivering, severe facial pain, headache, stomach pain, fatigue. treatment over 36 hours: ibuprofen, tylenol, cyclobenzaprine, tramodol, hot showers, massage, relaxation breathing. symptoms took 3-4 days to subside.
left temporal headache; Shingles; This is a spontaneous report from a contactable consumer (patient). A 57-year-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot Number: ER8729) via an unspecified route of administration in arm left on 21Apr2021 12:45 as dose 2, single (age at vaccination: 57 years) for COVID-19 immunisation. Medical history included multifocal GBM responsive, chicken pox as a child to treatment, both from an unknown date and unknown if ongoing. Concomitant medications included simvastatin (AVASTIN [SIMVASTATIN]) infusion; temozolomide (TEMODAR) oral, both taken for an unspecified indication, start and stop date were not reported. Historical vaccine includes bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot Number: EP7534) via an unspecified route of administration in arm right on 23Mar2021 01:00 as dose 1, single for COVID-19 immunisation. No other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No covid prior vaccination and did not tested COVID post vaccination. No known allergies. On 22Apr2021 at 12:00, the patient experienced left temporal headache reduced by Tylenol for two days, followed by small outbreak of shingles on left front scalp. No treatment received and no history of shingles. The clinical outcome of the event left temporal headache was resolving and the event shingles was not resolved.  No follow-up attempts are possible. No further information is expected.
Information has been received regarding a case in litigation from a lawyer, an elderly male patient of unknown age, and his spouse. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On an unknown date in 2010, at approximately 73 years of age, the patient was administered the ZOSTAVAX vaccine by a healthcare provider (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a healthcare provider for the following injury resulting from his ZOSTAVAX use: Ocular shingles. The outcome of the ocular shingles is unknown. The patient claimed damages as a result of: injury to themselves, loss of consortium, loss of services, and economic losses. Upon internal review, ocular shingles was determined to be medically significant. Additional information has been requested.
The same reaction from both shots, a hot large (shoulder to elbow) red, itchy rash with a small white patch with a red center. The patch and red center were NOT the injection site. The reaction appeared on March 8 2021 after the first dose, and on March 29 after the second dose (which was administered on March 27, 2021 at 10:00 a.m.). On March 30 I still have both rashes.
2-3 hours after the vaccine I had a sting from the shot that I could feel in the muscle and that's how the flu is kind of like but it carried into the next day with high pain. I also had dry mouth and it could be I'm thinking too much of it but I thought it was weird and it happened right away within the first hour after the vaccine, and then the pain came in a couple of hours after that. I did put ice on my arm as well. The 2nd day around 1 PM I had to lay down and I started putting ice on it and took ibuprofen because it hurt. The 3rd day I could move it a lot better and it's more manageable and realistically it's gone. So basically the first days it hurt like the flu shot would, but this pain was worse than the flu shot.
This spontaneous report as received from a nurse refers to a 47 year old female patient with asthma, spinal stenosis, environmental allergies, allergy to sulfa drugs, codeine, acetaminophen, VICODIN, Tramadol and history of anxiety. On 13-MAY-2014, the patient was vaccinated with a dose of PNEUMOVAX 23 0.5 ml, intramuscularly injection in the right deltoid (lot#, expiry date unspecified). Concomitant therapies included CELEXA 20 mg, XYZAL 5 mg, albuterol (manufacturer unknown) as needed, ranitidine 150 mg twice daily and FLOVENT two puffs twice daily. On 14-MAY-2014, the patient developed swelling, warmness, pain at the injection site of right deltoid. The patient sought medical attention, came into office and was treated with DEXAMETHASONE injection in the deltoid area, ALEVE, and cold compress as needed. No diagnostic test were provided. The outcome of events was unknown. The relatedness between events and PNEUMOVAX 23 was not reported. Additional information is not expected.
Initial report received on 20 September 2013 from a consumer. this case is one of two cases reported by the same reporter, who each experienced adverse events following administration of FLUZONE HD Lot # UT761AA. The reporter in this case was also the reporter for case # 2013-09720. A 69 year old female was vaccinated on 12 September 2013 intramuscularly into the left deltoid with FLUZONE HD, lot # reported as UT761AA and to be confirmed. The reporter denied that the patient had any illness at the time of vaccination or any pre-existing allergies or medical conditions. On 12 September 2013, time not specified, the patient experienced redness and pain at the injection site. The patient was evaluated by a physician, date not reported and was prescribed BACTRIM DS, dose and route not reported. The reporter stated that the patient's condition has improved. Laboratory tests were not reported. The patient outcome was reported as unknown. Documents held by sender: None
Really sore shoulder. Couldn?t raise my arm for two days and still hurts.   SHOT WAS GIVEN TOO HIGH
Information has been received from a physician concerning an 18 year old female patient who on 14-JAN-2008 was vaccinated with the first dose of GARDASIL vaccine (yeast) (lot # 659653/1448U) and on 14-MAR-2008 was vaccinated with the second dose of GARDASIL vaccine (yeast) (lot # 660387/1967U). Concomitant therapy included hormonal contraceptives ALEESE. The physician reported that on 18-APR-2008, the patient developed Bell's palsy after administration of two doses of HPV vaccine. The nurse reported that the patient was nit evaluated in her office. The patient was evaluated by her family physician. Subsequently, the patient recovered from BELL'S palsy. The patient sought medical attention via telephone. Additional information has been requested. No further information is available.
Vaccines was administered beyond use date after thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccines was administered beyond use date after thaw process) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     It was unknown if patient was ever diagnosed with/ tested positive for COVID-19. It was unknown if patient had acute illnesses at the time of vaccination and up to one month before or chronic/ long-lasting health conditions.     On 27-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 27-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccines was administered beyond use date after thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccines was administered beyond use date after thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient age was reported as 35 years and 6 months.   No concomitant medication was reported.  Vaccine number 1 NDC code was reported as 80777-0273-99. The patient did not had any adverse reactions after the administration of the vaccines.  No treatment medication was reported.
Pt anxious prior to vaccine admin. post vaccination pt. sat on floor. When Transferred to wheelchair pt syncopal event occured (<10 sec) pt. was assisted to wheel chair. pale skin / lips. pt responded appropriately to conversation post syncope.
starting to feel lethargic and weak.  Had menses with increased blessed.  Called physician to have blood  work done to see if I was experiencing anemia.  Blood work complete on 12/31/2020.  On 1/3/2021, I woke up with blood blisters all over the inside of my mouth  and petechia on my trunk and bilateral upper and lower extremities.  I called my primary physician to report the symptoms.  He suggested to go to the ER if my symptoms worsened.  Later that evening I started with a nose bleed and did go to the ER.  Upon arrival to the ER, my platelet count was 9.  I was admitted to the hospital and diagnosed with ITP.
This patient received the Bexsero State vaccine instead of the Private vaccine. A private  Bexsero vaccine was transferred to the state stock to replace the dose. Bexsero state vaccine given: Lot # EN939 Expiration date: 10/31/2024 NDC:58160-976-02 Manufacturer: GlaxoSmithKline  Bexsero Private vaccine transferred to state stock: Lot # J52PN Expiration date: 03/31/2024 NDC: 58160-976-02 Manufacturer: GlaxoSmithKline
rt deltoid area is swollen 2/3 of arm, tender, red, hot, indurated; pt was seen in ER 18OCT95 f/u in 2 days
Shingles shot given by RPh. Flu shot given by RPh. Pneumonia shot given at Dr's office. Spoke with patient at Dr's office - she will call back. On 10/17/13: Per pt she is experiencing "thumping" in left arm after having flu shot 9/26/13. She thinks it is related to flu shot because it started after she got the shot and she says it "thumps" once a day at least. The pt had also reported that dizziness occurred when she got her shingles shot 8/30/13, which has resolved. The pt also reported extreme pain in her right arm because of pneumonia shot she received at the Dr's office 10/16.
This spontaneous report was received from a physician via office manager refers to a patient of unknown age. On 01-MAY-2013, the patient was vaccinated with a dose of GARDASIL (lot # H020002, expiry date 08-AUG-2015), with the same lot of improperly stored GARDASIL. Concomitant medications were not reported. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Heat flash felt in head and neck region for approximately 15 minutes about 1 hour and 20 minutes post injection, then completely disappeared. Mild soreness/aching at injection site overnight. Overall, mild side effects.
Fog/haz in my head, effects my vision and I can't concentrate forget what I am in the middle of doing, headache's that come with it sometimes are mild but there, tired spells where I feel like I can't keep my eyes open or function.
a child devel a transient rash p/2 siblings were vax w/varicella vax;the siblings were vax on 22MAY95 & 23MAY95 pt devel rash which lasted 1-2 days;3JUL95 mom of children devel pruritic vesicular rash which lasted 4 days;dx chicken pox
Five hours after immunizations, pt. developed a vomiting episode. He became very pale and his breathing slowed. He passed out. Mom called an ambulance and was seen in Emergency Department. Dx vagal reaction to excessive vomiting.
flu; Initial information received on 25-Oct-2020 regarding an unsolicited valid non-serious social media case from a consumer (patient).  This case involves a patient of unknown demographics, who reported it gave me the flu (influenza), when received Influenza vaccine.  The patient's medical history, medical treatments, vaccinations, condition medications and family history were not provided.  On an unknown date in 1978, the patient received influenza vaccine (batch number and expiry date unknown) via an unknown dose via unknown route at unknown administration site for prophylactic vaccination.  On an unknown date, (latency: unknown) after starting the suspect vaccine therapy, the patient stated that it gave the flu (influenza) and haven't had one since.  It was reported haven't had one since  No lab data was reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the event outcome was unknown for flu.  There will be no information available on the batch number for this case.
No adverse reaction. Patient came in for Menactra and was given Hib instead due to it being placed in wrong box. Parent and Health Dept notified.
Nausea; Vomiting; headache; fever; chills; body aches; fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Jun2021 at 12:45 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included epilepsy and asthma.  The patient previously received erythromycin (MANUFACTURER UNKNOWN) on an unknown date and for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Jun2021 at 12:00, as a single dose for COVID-19 immunisation. On 29Jun2021, the patient experienced nausea, vomiting, headache, fever, chills, body aches and fatigue. Therapeutic measures were not taken as the result of adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the events nausea, vomiting, headache, fever, chills, body aches and fatigue were resolving at the time of report.  The lot number for BNT162b2 was not provided and will be requested during follow up
Had menstrual bleeding / clots that started 2 days after vaccine. Menstrual cycle last 3 days, changing tampons hourly passed large clots. Have had menstrual cycles every 10-15 days since receiving vaccine.
30 minutes after the injection moderate headache. 8 hours after the injection upset stomach and diarrhea. Next morning after 8 hours of sleep, I felt very fatigued, dizzy, lightheaded. By 11am the morning after the injection, my adverse reactions had subsided.
Itchy arm; Redness where shot was; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy arm) and VACCINATION SITE ERYTHEMA (Redness where shot was) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included APIXABAN (ELIQUIS), LISINOPRIL, ROSUVASTATIN, PRIMIDONE, METOPROLOL and PROPAFENONE for an unknown indication.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE PRURITUS (Itchy arm) and VACCINATION SITE ERYTHEMA (Redness where shot was). At the time of the report, VACCINATION SITE PRURITUS (Itchy arm) and VACCINATION SITE ERYTHEMA (Redness where shot was) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided. Patient stated  that she was on a blood thinner and received the vaccine.   This case was linked to MOD-2021-333693 (Patient Link).
I never got the 2nd dose/Is it ok to receive the 2nd dose months after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I never got the 2nd dose/Is it ok to receive the 2nd dose months after the first dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I never got the 2nd dose/Is it ok to receive the 2nd dose months after the first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I never got the 2nd dose/Is it ok to receive the 2nd dose months after the first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.The treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jun-2021: The Additional document was received on 19-06-2021 and had significant information. Added patient demographics.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Additional Details: patient fainted and fell to the floor and hit her head on the floor.  She was with her boyfriend who was able to catch her and prevent a more severe fall.  I went to the outside of the vaccination area and try to hold her head down and support it so she would not hit her head   she came to within a minute and  dioriented and confused.  she remembered that she was in target and that she received her covid 19 moderna vaccine approximately 5 min before incident
This spontaneous report was received from a pharmacist refers to a 67 year old patient (gender unknown). On 06-SEP-2013, the patient was vaccinated with a 0.65 ml dose of ZOSTAVAX (lot# J003798, expiry: 28-JUN-2014), subcutaneously and developed rash soon after receiving ZOSTAVAX. On 12-SEP-2013, the patient was diagnosed with chicken pox. Pharmacist states she reported to VAERS when she learned of rash and noted VAERS confirmation number. The patient went to see an unspecified infectious Disease physician for antiviral treatment. The patient has been receiving antiviral therapy for near 10 days. The outcome of chicken pox was unknown. Additional information has been requested.
The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 28-Feb-2022/Patient received expired dose after the 30 day use by date; The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 28-Feb-2022/Patient received expired dose after the 30 day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 28-Feb-2022/Patient received expired dose after the 30 day use by date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 28-Feb-2022/Patient received expired dose after the 30 day use by date) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 28-Feb-2022/Patient received expired dose after the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 28-Feb-2022/Patient received expired dose after the 30 day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 28-Feb-2022/Patient received expired dose after the 30 day use by date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 28-Feb-2022/Patient received expired dose after the 30 day use by date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was reported that the vial was initially stored in the refrigerator on 11-Jan-2022. The dose administered more than after 30 days. The vial did not undergo any temperature excursions. The patient had not reported adverse reaction to the HCP knowledge. No treatment information was reported.